Poor tolerability of lenvatinib in elderly patients ≥80 years old with hepatocellular carcinoma: A multicenter observational study
Kinoshita, Akiyoshi, Hagiwara, Noriko, Osawa, Akiyuki, Akasu, Takafumi, Matsumoto, Yoshihiro, Ueda, Kaoru, Saeki, Chisato, Oikawa, Tsunekazu, Koike, Kazuhiko, Saruta, Masayuki
Published in Journal of oncology pharmacy practice (01.04.2023)
Published in Journal of oncology pharmacy practice (01.04.2023)
Get more information
Journal Article
A case of an elderly patient with chronic hepatitis C exacerbated by chemotherapy for malignant lymphoma and improved by direct-acting antivirals therapy
Aoki, Yuma, Kinoshita, Akiyoshi, Osawa, Akiyuki, Kano, Tomohiro, Sato, Yuko, Mitsuyoshi, Yuki, Koike, Kazuhiko, Saruta, Masayuki
Published in Kanzo (01.04.2022)
Published in Kanzo (01.04.2022)
Get full text
Journal Article
The Geriatric Nutritional Risk Index Predicts Tolerability of Lenvatinib in Patients With Hepatocellular Carcinoma
Kinoshita, Akiyoshi, Hagiwara, Noriko, Osawa, Akiyuki, Akasu, Takafumi, Matsumoto, Yoshihiro, Ueda, Kaoru, Saeki, Chisato, Oikawa, Tsunekazu, Koike, Kazuhiko, Saruta, Masayuki
Published in In vivo (Athens) (01.03.2022)
Published in In vivo (Athens) (01.03.2022)
Get full text
Journal Article
A case of an elderly patient with chronic hepatitis C exacerbated by chemotherapy for malignant lymphoma and improved by direct-acting antivirals therapy
Aoki, Yuma, Kinoshita, Akiyoshi, Osawa, Akiyuki, Kano, Tomohiro, Sato, Yuko, Mitsuyoshi, Yuki, Koike, Kazuhiko, Saruta, Masayuki
Published in Kanzo (01.04.2022)
Published in Kanzo (01.04.2022)
Get full text
Journal Article